SCHEMBL8312154

SCHEMBL8312154

O=C1NC(=S)SC1=Cc1cccc(Cl)c1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.73
PIM2 Q9P1W9 1/20 0.73
DNM1 Q05193 1/20 0.72
NAT1 P18440 5/20 0.72
CISD1 Q9NZ45 2/20 0.72
ADAMTS5 Q9UNA0 3/20 0.70
MYC P01106 2/20 0.70
MAX P61244 2/20 0.70
CA2 P00918 1/20 0.69
EPHX1 P07099 1/20 0.69
CRHBP P24387 2/20 0.65
CRHR2 Q13324 2/20 0.65
MMP3 P08254 1/20 0.65
MMP13 P45452 1/20 0.65
PTP4A3 O75365 1/20 0.63
MEN1 O00255 1/20 0.63
RAB9A P51151 1/20 0.63
KMT2A Q03164 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312151 1.00 PIM1 (0.73) PIM1PIM2DNM1NAT1CISD1
SCHEMBL1250348 0.84 PIM1 (1.00) PIM1PIM2CISD1ADAMTS5
SCHEMBL2548389 0.84 PIM1 (1.00) PIM1PIM2CISD1ADAMTS5
SCHEMBL1250346 0.84 PIM1 (1.00) PIM1PIM2CISD1ADAMTS5
SCHEMBL10519622 0.84 PIM1 (0.74) PIM1PIM2NAT1CISD1MYC
SCHEMBL7562040 0.84 CISD1 (1.00) PIM1PIM2NAT1CISD1MYC
SCHEMBL7557609 0.84 NAT1 (1.00) PIM1PIM2NAT1CISD1ADAMTS5
SCHEMBL12892064 0.84 NAT1 (1.00) NAT1CISD1ADAMTS5MYCMAX
SCHEMBL8310946 0.84 NAT1 (1.00) NAT1CISD1ADAMTS5MYCMAX
SCHEMBL10519629 0.84 PIM1 (0.74) PIM1PIM2NAT1CISD1MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
CN-1091006-A Chemical compound as blood sugar lowering and treatment degenerative brain disorder LILLY CO ELI (US) 1994-08-24 CN disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed